Translate Bio, Inc. (CIK: 0001693415) EDGAR, Information, Filings... CompaniesBIO.Com

Translate Bio, Inc.

Mailing address
29 HARTWELL AVENUE, LEXINGTON, Delaware, 02421
Phone
617-945-7361
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Translate Bio, Inc. (CIK: 0001693415) is an American company incorporated in the state of Massachusetts. Head office is located at 29 HARTWELL AVENUE, LEXINGTON, Massachusetts, 02421. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Translate Bio, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

RaNA Therapeutics, Inc. from 2017-05-Jan to 2017-05-Jan

Owner	Filings	Transaction Date	Type of Owner
Sanofi	0001121404	Sep-14-2021	10 percent owner
Smith Brendan	0001857492	Apr-19-2021	officer: Chief Financial Officer
Sutherland Everett Rand	0001852880	Mar-22-2021	officer: President
KLARMAN SETH A	0000899869	Sep-18-2019	10 percent owner
BAUPOST GROUP LLC/MA	0001061768	Sep-18-2019	10 percent owner
Baupost Group GP, L.L.C.	0001738693	Sep-18-2019	10 percent owner
Demetri George	0001639147	Jul-12-2019	director
Wooster Richard	0001774790	Apr-24-2019	officer: Chief Scientific Officer
Plenge Robert M	0001773367	Apr-10-2019	director
TAKEDA PHARMACEUTICAL CO LTD	0001395064	Jan-08-2019	10 percent owner
Meyer Robert J.	0001735298	Jan-02-2019	director
Shire plc	0000936402	Jun-27-2018	10 percent owner
FORMELA JEAN FRANCOIS	0001030575	Jun-27-2018	director
GLAXOSMITHKLINE PLC	0001131399	Jun-27-2018	10 percent owner
LYNCH DANIEL	0001177082	Jun-27-2018	director
Renaud Ronald C JR	0001354434	Jun-27-2018	director, 10 percent owner, officer: See Remarks
Stampacchia Otello	0001361712	Jun-27-2018	10 percent owner
Atlas Venture Associates VIII, Inc.	0001451624	Jun-27-2018	10 percent owner
Atlas Venture Associates VIII, L.P.	0001451625	Jun-27-2018	10 percent owner
Atlas Venture Fund VIII, L.P.	0001451626	Jun-27-2018	10 percent owner
Beckman Daniella	0001513422	Jun-27-2018	director
Omega Fund IV, L.P.	0001528382	Jun-27-2018	10 percent owner
Omega Fund IV GP, L.P.	0001528383	Jun-27-2018	10 percent owner
Hughes Owen	0001575933	Jun-27-2018	director
Lim Richard J.	0001623720	Jun-27-2018	10 percent owner
Omega Fund IV G.P. Manager, Ltd.	0001624456	Jun-27-2018	10 percent owner
Omega Fund V GP Manager, Ltd.	0001641348	Jun-27-2018	10 percent owner
Omega Fund V, L.P.	0001641354	Jun-27-2018	10 percent owner
Omega Fund V GP, L.P.	0001641355	Jun-27-2018	10 percent owner
Paster Anne-Mari	0001652863	Jun-27-2018	10 percent owner
Gallagher Brian M. Jr.	0001709976	Jun-27-2018	director
Nessi Claudio	0001722050	Jun-27-2018	10 percent owner
Barbier Ann	0001737596	Jun-27-2018	officer: Chief Medical Officer
MRL Ventures Fund LLC	0001742519	Jun-27-2018	10 percent owner
Schroer John R.	0001744578	Jun-27-2018	officer: See Remarks
Burgess Paul D.	0001744627	Jun-27-2018	officer: General Counsel and Secretary
Heartlein Michael	0001744680	Jun-27-2018	officer: See Remarks
Cloghessy Paula	0001744682	Jun-27-2018	officer: See Remarks
Fenton Brian	0001744683	Jun-27-2018	officer: Chief Business Officer
Shire Human Genetic Therapies, Inc.	0001745009	Jun-27-2018	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Translate Bio, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001193125-21-282037 (34 Act) Size: KB	Sep-24-2021	001-38550 211276849
EFFECT	Document	Acc-no: 9999999995-21-003598 (33 Act) Size: KB	Sep-21-2021	333-237159 211268069
EFFECT	Document	Acc-no: 9999999995-21-003597 (33 Act) Size: KB	Sep-21-2021	333-232543 211268068
4/A	Document	Amendment to Statement of changes in beneficial ownership of securities Acc-no: 0001567619-21-017206 ( Act) Size: KB	Sep-16-2021
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001567619-21-017202 (34 Act) Size: KB	Sep-16-2021	005-90547 211258708
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056067 ( Act) Size: 0 KB	Sep-14-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056064 ( Act) Size: 0 KB	Sep-14-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056062 ( Act) Size: 0 KB	Sep-14-2021
4/A	Document	Amendment to Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056060 ( Act) Size: KB	Sep-14-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056057 ( Act) Size: 0 KB	Sep-14-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056055 ( Act) Size: 0 KB	Sep-14-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056051 ( Act) Size: 0 KB	Sep-14-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056049 ( Act) Size: 0 KB	Sep-14-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056047 ( Act) Size: 0 KB	Sep-14-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056045 ( Act) Size: 0 KB	Sep-14-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056041 ( Act) Size: 0 KB	Sep-14-2021
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-21-056038 ( Act) Size: 0 KB	Sep-14-2021
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-21-272943 (33 Act) Size: KB	Sep-14-2021	333-253696 211252953
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-21-272941 (33 Act) Size: KB	Sep-14-2021	333-237158 211252932
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-21-272934 (33 Act) Size: KB	Sep-14-2021	333-231746 211252907

Recent 20 filings. View all Translate Bio, Inc. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Translate Bio, Inc. overview
Translate Bio, Inc. job
Translate Bio, Inc. stock
Translate Bio, Inc. ownership
Translate Bio, Inc. CEO
Translate Bio, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.